Pilot Study to Develop 3 Tesla MRI for Evaluation of Renal Tumors
Status unconfirmed
Conditions studied: Kidney Neoplasms
In brief
The goal of this clinical research study is to find out if "3 Tesla" MRI is as good as CT scan in the evaluation of kidney tumor(s). Objectives: To provide preliminary data to enable subsequent development of an MRI protocol at 3 Tesla for evaluation of renal tumors and their vascular supply, which can be adopted in patients who are unable to undergo CT evaluation.
Key facts
- Study ID
- NCT00507884
- Run by
- M.D. Anderson Cancer Center
- People needed
- 45
- Starts
- 2005-03-01
- Expected to finish
- 2022-09-01
- Last updated by the study team
- 2020-12-31
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients who have undergone or are due to undergo a CT Renal Protocol study, in the course of pre-operative evaluation for renal tumor surgery.
- Written informed consent will be obtained.
You may not qualify if…
- Patients with an allergy to both gadopentetate dimeglumine and gadodiamide MRI contrast agents.
- Patients with certain metallic implants, e.g., cardiac pacemakers, cardiac defibrillators, aneurysm clips, neurostimulators, and certain metallic foreign bodies. Implanted medical devices must be MRI compatible at 3.0 Tesla field strengths.
- Patients with claustrophobia, or requiring sedation for the MRI scan.
Where it is running
- University of Texas MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.